Having trouble accessing articles? Reset your cache.

Genzyme, LabCorp deal

LabCorp will acquire Genzyme's Genzyme Genetics testing business for $925 million in cash. LabCorp said the deal will expand

Read the full 190 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE